Zhongyang Lin

A longitudinal single-cell RNA sequencing atlas of 441 samples from 241 patients across ten cancer entities is assembled to map treatment-associated remodeling of the tumor immune microenvironment (TIME), establishing immunotype transitions as a central determinant of ICI efficacy.